Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Change in Receivables (2017 - 2025)

Dare Bioscience's Change in Receivables history spans 8 years, with the latest figure at $191851.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 55.42% year-over-year to $191851.0; the TTM value through Dec 2025 reached $331026.0, changed N/A, while the annual FY2025 figure was $331026.0, N/A changed from the prior year.
  • Change in Receivables reached $191851.0 in Q4 2025 per DARE's latest filing, up from $181041.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $9.4 million in Q2 2022 to a low of -$8.9 million in Q3 2022.
  • Average Change in Receivables over 5 years is $45559.4, with a median of $69587.5 recorded in 2025.
  • The largest YoY upside for Change in Receivables was 1150.56% in 2021 against a maximum downside of 7784.35% in 2021.
  • A 5-year view of Change in Receivables shows it stood at $989070.0 in 2021, then plummeted by 159.54% to -$588882.0 in 2022, then soared by 69.34% to -$180547.0 in 2023, then surged by 338.35% to $430325.0 in 2024, then crashed by 55.42% to $191851.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Change in Receivables are $191851.0 (Q4 2025), $181041.0 (Q3 2025), and -$41866.0 (Q2 2025).